Skip to Main Content

Paper Details

Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma.
J Ovarian Res
2
2022
Author NameAffiliation
Richard de BorjaUniversity of Toronto
Blaise A ClarkeUniversity Health Network
  • 1 - 2

Datasets

Release 1.2